ACLX: Arcellx, Inc. Common Stock Company Profile & Statistics

About

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

Info & Links

CEO

Rami Elghandour

Headquarters

800 BRIDGE PARKWAY
REDWOOD CITY, CA 94065, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

163

Arcellx, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

3.41B

Enterprise Value

3.30B

Enterprise Value/EBITDA(ttm)

-22.33

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

22.77

Price to Book(mrq)

7.30

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-25.94%

Profit Margin(ttm)

-131.36%

Return on Equity(ttm)

-8.28%

Return on Invested Capital(ttm)

-22.74%

Return on Assets(ttm)

-5.21%

Income Statement

Revenue(ttm)

107.94M

Revenue Per Share(ttm)

1.96

Gross Profit(ttm)

107.94M

EBITDA(ttm)³

-147.84M

Net Income Available to Common(ttm)

-107.35M

Diluted EPS(ttm)

-0.71

Share Statistics

Beta (5Y Monthly)

0.29

52-Week Change

15.87%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

54.94M

Dividend Yield

0.00%

Float⁴

50.70M

% Held by Insiders

6.24%

% Held by Institutions

96.03%

Balance Sheet

Total Cash(mrq)

587.58M

Total Cash Per Share(mrq)

10.69

Total Debt(mrq)

230.00K

Total Debt/Equity(mrq)

0.05%

Current Ratio(mrq)

4.78%

Quick Ratio(mrq)

4.29%

Book Value Per Share(mrq)

8.38

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.56

Free Cash Flow(ytd)

-96.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ACLX

Arcellx, Inc. Common Stock

Arcellx, Inc. Common Stock Profile